TruthArchive.ai - Related Video Feed

The speaker discusses the use of mRNA in food and mentions a presentation about genetically engineering mosquitoes to deliver vaccines through mosquito bites. They mention that the Gates Foundation is funding this research, although they don't have proof of its viability. The speaker clarifies that they are not suggesting that the mosquitoes are currently injecting anyone with anything, but they have evidence that efforts are being made to enable mosquito injections.

Speaker 0 suggests solving the problem by spraying hotspots in a specific area to test its effectiveness. Speaker 1 mentions that the district commissioner informs people about a new medicine that kills mosquitoes and other insects. Some Africans are skeptical, fearing poisoning or witchcraft. To prove its safety, the entomologist eats porridge sprayed with the solution, but the audience remains unconvinced. The chief spokesman objects, believing the medicine is a dangerous poison that could harm the entire tribe.

CRISPR, a lab technique, can alter mosquito DNA to decrease their population or prevent them from carrying parasites. Discussions are underway with African countries to determine the necessary tests and trials before implementing this technique. Although it will take several years to obtain country approvals, the potential to reduce mosquito populations and eliminate malaria locally is promising. The speaker even brought some mosquitoes to the auditorium to provide firsthand experience. They emphasize that it is unfair for only poor people to face this issue.

In Medellin, Colombia, the world's largest mosquito factory is producing 30 million mosquitoes per week for the World Mosquito Program. By introducing Wolbachia bacteria into the mosquitoes, their ability to transmit diseases like dengue is stopped. The process involves releasing Wolbachia-infected mosquitoes into the wild population through mating. The factory houses mosquito eggs, larvae, and pupae, which are sorted by sex to manipulate the sex ratio. The mosquitoes are fed blood and then either packaged as eggs or released as adults into the field. With over half the world's population at risk of these diseases, the goal is to scale and deliver this solution to communities in need.

Hi. I'm Scott O'Neill here in Medellin, Colombia today, and I'm at the world's biggest mosquito factory for the World Mosquito Program. We're making in here 30,000,000 mosquitoes a week. We've been able to bring the solution of Wolbachia mosquitoes to the city. When this bacteria called Wolbachia gets introduced into the mosquito, it stops their ability to transmit dengue. We release mosquitoes that have Wolbachia, and then they go and mate, and Wolbachia gets passed into the wild mosquito population. If we're going to control these diseases in all the tropical cities of the world, it's gonna require a lot of mosquitoes. The mosquito life cycle starts with the egg, and in this room, we've got a lot of eggs. Each one of these strips, these tiny black dots are up to 10,000 mosquito eggs.

We are discussing regulation and the use of CRISPR to reduce mosquito populations and combat malaria. We are working with African countries on necessary trials. It will take time to get approvals, but the potential to eliminate disease locally is promising. Malaria is transmitted by mosquitoes, and we are demonstrating this by releasing some in the auditorium. Everyone should understand the impact, not just the poor.

In Medellin, Colombia, the world's largest mosquito factory is producing 30 million mosquitoes per week for the World Mosquito Program. They are using Wolbachia bacteria to stop the transmission of diseases like dengue, Zika, and chikungunya. The factory starts with mosquito eggs, which hatch into larvae and then pupae. The males and females are sorted, with more females being desired. The adult mosquitoes are either packaged as eggs in gelatin capsules or released directly into the field. The goal is to scale this solution and deliver it to communities worldwide that are affected by these diseases.

The speaker states that mRNA in food is a critical issue, but also highlights the potential for transgenic mosquitoes to deliver vaccines via saliva. They reference a presentation about producing a transgenic mosquito as a "flying syringe" to deliver protective vaccines. The speaker claims the Gates Foundation is funding genetic engineering of mosquitoes with the intention of using mosquito bites for vaccination. While they don't have definitive proof of its viability, they assert that this research is underway. The speaker clarifies they are not claiming current mosquitoes are injecting people with anything. However, they state they have indisputable evidence that efforts are being made to enable mosquitoes to inject people with substances in the future.

There is a technique called CRISPR in the lab that can manipulate mosquito DNA to reduce their population or eliminate the disease they carry. Discussions are ongoing with African countries to determine the necessary tests and trials before implementing this solution. However, obtaining country approvals will take several years. Despite the time frame, the potential of reducing mosquito population and eradicating the disease locally makes this approach highly promising.

We are in Medellin, Colombia at the world's largest mosquito factory for the World Mosquito Program. We produce 30 million mosquitoes a week to combat diseases like dengue and Zika by introducing Wolbachia bacteria into the mosquito population. The process starts with eggs, then larvae, pupae, and finally adult mosquitoes. We sort males from females to control the sex ratio. The mosquitoes are fed blood and then released into the field to mate and spread Wolbachia.

The situation has been horrific, leading to a shift in research and development budgets. Current vaccines primarily focus on improving individual health but only slightly reduce transmission. There is a need for a new approach to vaccine development that effectively blocks transmission.

In 10-15 years, I hope to see a significant impact on global health, particularly in reducing mortality rates in developing countries. We aim for improvements in diseases like malaria, with the ultimate goal of easing challenges in education and nutrition. Our foundation uses data-driven dashboards to track progress and share learnings with others. With a budget of $3 billion annually, we have high expectations for the impact we can make. Thank you for the opportunity to discuss our work at the World Economic Forum.

I'm Scott O'Neill in Medellin, Colombia at the world's largest mosquito factory for the World Mosquito Program. We produce 30 million Wolbachia mosquitoes weekly to combat diseases like dengue. The Wolbachia bacteria stops mosquitoes from transmitting dengue. We breed mosquitoes from eggs to adults, sorting males and females to control the sex ratio. The females are released into the field after feeding on blood. Our goal is to reduce mosquito-borne diseases in tropical cities worldwide.

Researchers are conducting research on injecting mosquitoes with vaccines, which the speakers find concerning. They question the containment of these mosquitoes once released and express worries about the potential negative consequences, citing previous instances of invasive species. The modified mosquitoes have already been released in Florida, and the speakers mention the occurrence of malaria cases in Florida and Texas. They express concern about the decision-making process and the potential widespread impact of these mosquitoes. They criticize the idea of blindly trusting the researchers and highlight the need for public discussion and political involvement. The speakers liken the situation to a horror movie plot.

Malaria eradication is challenging, but gene drive technology could change the genetics of mosquitoes to help achieve this goal. Mosquitoes can be genetically modified to act as "flying syringes" that deliver malaria vaccines when they bite humans. However, there are concerns about the potential risks of spreading malaria and the ethical implications of genetically modifying mosquitoes without informed consent. Despite these concerns, the development of new tools and technologies is crucial for malaria eradication.

This is a challenging time where progress is at risk due to tight budgets. Aid has decreased by $30 billion this year. Cuts in health resources, combined with the financial situations of low-income countries, will cause setbacks. Without available vaccines, babies will die. Measles epidemics will continue due to fewer resources for primary health care systems and vaccines. Parents will lose children whose lives could have been saved by a 30¢ vaccine.

In the future, there might be a deadly airborne disease. To effectively handle it, we need a global infrastructure that enables us to detect, isolate, and respond to it swiftly. This infrastructure should be in place not only in our country but worldwide. By investing in this infrastructure, we can be better prepared to tackle future outbreaks, such as a new strain of flu similar to the Spanish flu, that may emerge in the next five or ten years.

For example, there's more money put into baldness drugs than are put into malaria. Now baldness is it's terrible thing. And rich men are afflicted. And so that's why that priority has been set. But malaria, even the million deaths a year caused by malaria, greatly understate its impact. Over two hundred million people at any one time are suffering from it. It means that you can't get the economies in these areas going because there's just it holds things back so much. Malaria is, of course, transmitted by mosquitoes. I brought some here so you could experience this. We'll let those roam around the auditorium a little bit there. There's no reason only poor people should have have the experience. Those mosquitoes are not not infect

I will discuss pandemic preparedness today. Based on my experience, I can say that the next administration will face challenges with chronic infectious diseases and unexpected outbreaks. In my 32 years as NIAID director, history shows that these challenges are inevitable for the new administration.

In this video, the speaker discusses the challenges of eradicating malaria and the potential use of genetically modified mosquitoes to deliver vaccines. They express concerns about the spread of malaria if the genetic modification fails and question the ethical implications of releasing modified mosquitoes without informed consent. Another speaker highlights the importance of considering climate change and its impact on the geographic range of disease-carrying mosquitoes. They emphasize the need to prevent, prepare for, and respond to emerging pathogens, using the systems and tools developed for COVID-19 as examples. The speaker also mentions the efforts made by countries to strengthen their healthcare systems for various diseases.

Due to budget constraints and a $30 billion cut in global health aid this year, progress is at risk and low-income countries will experience setbacks. Without sufficient resources for primary healthcare systems and vaccines, easily preventable diseases will continue to cause fatalities. The speaker highlighted the impact of resource cuts, emphasizing that a $0.30 vaccine could save a child's life. Although trend lines will reverse, the speaker believes that progress will resume with restored resources and innovations in drugs and vaccines. The timeline for recovery is uncertain, but the speaker is confident that advancements will continue.

The speaker believes another event similar to the COVID-19 pandemic could occur. While an invisible pandemic might not be successful again, the WHO's list of potential pandemics includes hemorrhagic viruses. The speaker believes that if a pandemic involved people bleeding from the mouth, nose, eyes, and ears, it would terrify the public.

Cases of Lyme disease are increasing, with the CDC estimating half a million cases annually. The rise coincided with the peak of the US biological weapons program in the mid-seventies, leading to the emergence of Lyme arthritis, Rocky Mountain spotted fever, and Babesia. These diseases clustered near a government testing facility, suggesting a sinister origin. Nature cannot be controlled, and the implications are disturbing.

Mosquito bites can be annoying, but some people get bitten a lot more than others. Whether it's on a date, grocery shopping, commuting, or just walking down the street, mosquitoes seem to be everywhere. Getting bitten by mosquitoes every day can be really frustrating. Beyond being annoying, some mosquitoes carry diseases that can have long-lasting effects on your health. So next time you think someone is overreacting to a mosquito bite, remember that some people experience them all the time. And when we say mosquito bites, we actually mean microaggressions.

We conducted a study in Senegal to see how Ivermectin, given to people for river blindness, affected mosquitoes that transmit malaria. By catching mosquitoes before and after treatment, we found that the drug killed most adult mosquitoes, particularly the ones that transmit malaria. Although the total number of mosquitoes didn't decrease significantly, the drug effectively eliminated the old females responsible for spreading malaria.